Back to Search Start Over

Sex-based differences in the comprehensive geriatric assessment in elderly hospitalized patients with non-valvular atrial fibrillation.

Authors :
Armentaro G
Pastori D
Castagna A
Condoleo V
Cassano V
Pastura CA
Francica M
Benincasa C
D'Alterio N
Arturi F
Ruotolo G
Sciacqua A
Source :
European journal of internal medicine [Eur J Intern Med] 2024 Jul; Vol. 125, pp. 74-81. Date of Electronic Publication: 2024 Mar 27.
Publication Year :
2024

Abstract

Atrial fibrillation (AF) represents the most common supraventricular arrhythmia, with a prevalence of 1-3 % in the world population. Growing evidences show that AF plays an important role as a risk factor for the development of cognitive impairment (CoI) and dementia, depression and functional limitation. The purpose of the study is to evaluate, in a large cohort of elderly hospitalized patients with nonvalvular AF (NVAF) on direct oral anticoagulants (DOACs) therapy, the prevalence of CoI, depression, and functional limitation, and to assess the different variables that may be detrimental or protective on the risk of CoI or functional limitation. 1004 elderly patients were enrolled, 384 men and 620 women, with a mean age of 84±7.1 years. The two groups were comparable for the main study variables, except for age, prevalence of hypertension and CKD, which were higher in women, while ischemic heart disease was higher in men. In addition, the two groups differed in the CHA <subscript>2</subscript> DS <subscript>2</subscript> VASc score 5.3 ± 1.3 vs 4.2 ± 1.4 pts (p < 0.0001) and HAS-BLED score 2.5 ± 0.7 vs 2.3 ± 0.8 pts (p = 0.009) that were significantly higher in women. Our study revealed that in a cohort of elderly patients hospitalized with AF taking DOACs, CoI and disability are widely represented, and female sex increases the risk of being affected by CoI by about 3-fold, while improvement of functional limitations reduce this risk by about 15 %. In addition, CoI and depressive symptoms increase the risk of functional impairment about 2-fold and 28 % respectively, while antihypertensive and anti-diabetic therapy reduce this risk.<br />Competing Interests: Declaration of competing interest The authors declare they have no conflict of interest.<br /> (Copyright © 2024. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1879-0828
Volume :
125
Database :
MEDLINE
Journal :
European journal of internal medicine
Publication Type :
Academic Journal
Accession number :
38548512
Full Text :
https://doi.org/10.1016/j.ejim.2024.03.014